Biotech Counts in Cambridge

After working as a research fellow for nearly seven years at the University of California, San Francisco, Alex Duncan wanted to settle down and raise a family. Rather than stay in the United States, he decided to put down roots in Cambridge, England. The decision wasn't difficult, since both he and his wife were from the United Kingdom, and he had done graduate work at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge. "Cambridge is a vibrant university town with a

Written byTed Agres
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

"Cambridge is a vibrant university town with an academic atmosphere that's very collegial," says Duncan, vice president for drug discovery at Cambridge Antibody Technology (CAT), a spin-off company founded 12 years ago using MRC research. "It's a beautiful place to live with lots of bright, interesting people around--not just scientists, but people in economics, business, history, and the arts. The area is just booming."

Bursting at the seams might be a more apt description. Cambridge is a biotechnology powerhouse where centuries of academic excellence--dating from before Sir Isaac Newton--come face to face with the largest and fastest growing concentration of life sciences companies and research institutions in Britain. "Cambridge has a creative, inventive environment, especially in the biosciences, because of its extremely strong academic background," says Tony Talbot, chief executive of Iceni BioDiscovery, a 13-person start-up company developing cell transplantation therapies for diabetes and other diseases. "It attracts very high-quality, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies